| 1.32 0.08 (6.45%) | 05-13 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 1.76 |
1-year : | 2.06 |
| Resists | First : | 1.51 |
Second : | 1.76 |
| Pivot price | 1.3 |
|||
| Supports | First : | 1.23 |
Second : | 1.05 |
| MAs | MA(5) : | 1.34 |
MA(20) : | 1.27 |
| MA(100) : | 1.31  |
MA(250) : | 2.58 |
|
| MACD | MACD : | 0 |
Signal : | 0 |
| %K %D | K(14,3) : | 64.4 |
D(3) : | 68.5 |
| RSI | RSI(14): 53.1 |
|||
| 52-week | High : | 5.63 | Low : | 0.77 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ SLSN ] has closed below upper band by 45.9%. Bollinger Bands are 19.5% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 1.33 - 1.34 | 1.34 - 1.34 |
| Low: | 1.21 - 1.21 | 1.21 - 1.22 |
| Close: | 1.31 - 1.32 | 1.32 - 1.33 |
Solésence, Inc., formerly Nanophase Technologies Corporation, is a developer and manufacturer of clean, inclusive, mineral-based skincare and makeup products. The company partners with global and indie brands, leveraging its proprietary Active Stress Defense™ technology suite to bring environmental protection beauty products to market.
Tue, 12 May 2026
[10-Q] SOLESENCE, INC. Quarterly Earnings Report - Stock Titan
Tue, 12 May 2026
Solesence, Inc. - Common stock (Nasdaq:SLSN) Stock Quote - The Chronicle-Journal
Tue, 12 May 2026
Solésence (NASDAQ: SLSN) Q1 2026 revenue falls to $13M, swings to loss - Stock Titan
Mon, 04 May 2026
SLSN Insider Trade: CFO Riffner Sells 60K Shares May 04, 2026 - Meyka
Tue, 28 Apr 2026
SLSN Insider Trade: CFO Laura Riffner’s $210K Stock Activity April 28 - Meyka
Fri, 24 Apr 2026
SLSN Stock: CFO Laura Riffner’s $210K Insider Trade April 24, 2026 - Meyka
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Consumer Defensive
|
|
|
Industry:
Household & Personal Products
|
|
| Shares Out | 71 (M) |
| Shares Float | 18 (M) |
| Held by Insiders | 73.1 (%) |
| Held by Institutions | 6.2 (%) |
| Shares Short | 847 (K) |
| Shares Short P.Month | 739 (K) |
| EPS | 0.01 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0.25 |
| Profit Margin | 2.8 % |
| Operating Margin | 1.4 % |
| Return on Assets (ttm) | 1.9 % |
| Return on Equity (ttm) | 10.9 % |
| Qtrly Rev. Growth | -0.7 % |
| Gross Profit (p.s.) | 0.22 |
| Sales Per Share | 0.87 |
| EBITDA (p.s.) | 0.03 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -9 (M) |
| Levered Free Cash Flow | -12 (M) |
| PE Ratio | 66 |
| PEG Ratio | 0 |
| Price to Book value | 5.28 |
| Price to Sales | 1.5 |
| Price to Cash Flow | -10.88 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|